NIOX Group PLC
82C
Company Profile
Business description
NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world.
Contact
1 Robert Robinson Avenue
The Magdalen Centre
The Oxford Science Park
OxfordOX4 4GA
GBRT: +44 3303309356
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
84
Stocks News & Analysis
stocks
Insignia Financial: Revised deal still attractive
The offer price is well above our fair value.
stocks
Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?
With the monetization of GenAI, here’s what we think of Alphabet’s stock
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,001.40 | 59.90 | 0.67% |
CAC 40 | 7,850.43 | 106.02 | 1.37% |
DAX 40 | 24,217.10 | 175.20 | 0.73% |
Dow JONES (US) | 44,804.54 | 302.10 | 0.68% |
FTSE 100 | 9,061.49 | 37.68 | 0.42% |
HKSE | 25,538.07 | 408.04 | 1.62% |
NASDAQ | 20,970.72 | 78.03 | 0.37% |
Nikkei 225 | 41,171.32 | 1,396.40 | 3.51% |
NZX 50 Index | 12,794.06 | 39.68 | -0.31% |
S&P 500 | 6,339.12 | 29.50 | 0.47% |
S&P/ASX 200 | 8,737.20 | 60.00 | 0.69% |
SSE Composite Index | 3,582.30 | 0.44 | 0.01% |